Goldman Sachs Group Inc Ionis Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 652,518 shares of IONS stock, worth $21.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

652,518

Previous 652,518 -0.0%

Holding current value

$21.9 Million

Previous $19.7 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$30.17 - $34.97 $8.28 Million - $9.59 Million	274,310 Added 72.53%	652,518 $19.7 Million
Q4 2024 Feb 11, 2025	BUY	$33.73 - $40.36 $4.81 Million - $5.75 Million	142,498 Added 60.45%	378,208 $13.2 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $3.71 Million - $4.8 Million	-92,595 Reduced 28.2%	235,710 $9.44 Million
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $4.66 Million - $6.1 Million	127,925 Added 63.84%	328,305 $15.6 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $7.61 Million - $9.69 Million	-181,002 Reduced 47.46%	200,380 $8.69 Million
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $1.89 Million - $2.25 Million	43,555 Added 12.89%	381,382 $19.3 Million
Q3 2023 May 14, 2024	SELL	$38.5 - $47.13 $1.68 Million - $2.05 Million	-43,555 Reduced 11.42%	337,827 $15.3 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $5.75 Million - $7.04 Million	149,455 Added 79.34%	337,827 $15.3 Million
Q2 2023 May 14, 2024	SELL	$34.73 - $43.33 $8.12 Million - $10.1 Million	-233,726 Reduced 55.37%	188,372 $7.73 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $8.12 Million - $10.1 Million	-233,726 Reduced 55.37%	188,372 $7.73 Million
Q1 2023 May 14, 2024	SELL	$33.58 - $41.2 $16.8 Million - $20.6 Million	-500,313 Reduced 54.24%	422,098 $15.1 Million
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $16.8 Million - $20.6 Million	-500,313 Reduced 54.24%	422,098 $15.1 Million
Q4 2022 May 14, 2024	SELL	$37.12 - $46.52 $13.7 Million - $17.1 Million	-368,154 Reduced 28.53%	922,411 $34.8 Million
Q4 2022 Feb 13, 2023	SELL	$37.12 - $46.52 $13.7 Million - $17.1 Million	-368,154 Reduced 28.53%	922,411 $34.8 Million
Q3 2022 May 14, 2024	BUY	$36.54 - $48.66 $9.09 Million - $12.1 Million	248,741 Added 23.88%	1,290,565 $57.1 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $9.09 Million - $12.1 Million	248,741 Added 23.88%	1,290,565 $57.1 Million
Q2 2022 May 14, 2024	BUY	$31.71 - $43.0 $20.9 Million - $28.4 Million	660,442 Added 173.17%	1,041,824 $38.6 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $2.77 Million - $3.76 Million	87,498 Added 9.17%	1,041,824 $38.6 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $10.9 Million - $13.5 Million	365,028 Added 61.94%	954,326 $35.3 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $321,098 - $440,083	-12,538 Reduced 2.08%	589,298 $17.9 Million
Q3 2021 Nov 10, 2021	BUY	$33.54 - $40.55 $20.2 Million - $24.4 Million	601,836 New	601,836 $20.2 Million

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Ionis Pharmaceuticals Inc Transaction History